Vaxcyte Inc (PCVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 386,200 | 397,048 | 410,046 | 0 | N/A |
| TOTAL | $389,004 | $400,835 | $413,057 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 3,272 | 2,539 | 2,753 | N/A | N/A |
| Other Non-Current Assets | 550 | 442 | 438 | 0 | 0 |
| TOTAL | $3,822 | $2,981 | $3,191 | $N/A | $N/A |
| Total Assets | $392,826 | $403,816 | $416,248 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 29,785 | 10,685 | 2,556 | 0 | 0 |
| Accrued Expenses | 3,766 | 2,870 | 3,297 | 0 | N/A |
| Other current liabilities | 14 | 27 | 25 | 0 | N/A |
| TOTAL | $46,861 | $39,612 | $32,894 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 122 | 129 | 144 | 0 | 0 |
| TOTAL | $122 | $129 | $144 | $N/A | $N/A |
| Total Liabilities | $46,983 | $39,741 | $33,038 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,328 | 50,950 | 50,924 | N/A | N/A |
| Common Shares | 54 | 54 | 54 | 0 | N/A |
| Retained earnings | -198,564 | -177,827 | -156,809 | 0 | N/A |
| TOTAL | $345,843 | $364,075 | $383,210 | $0 | $N/A |
| Total Liabilities And Equity | $392,826 | $403,816 | $416,248 | $0 | $0 |